ATOH8 and breast carcinoma: Functional validation experiments revealed that ATOH8 strongly inhibited proliferation, migration, and invasion of breast cancer cells, whereas DNASE2 significantly enhanced migration and invasion of cellular behaviors, indicating the inhibitory and promotive roles of ATOH8 and DNASE2 in the pathogenesis of breast cancer, respectively.